back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-09-29 13:48 Tx date 2022-09-28 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
371,083 | |
| Filed 2021-11-15 14:03 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+42,100 vol |
326,083 | |
| Filed 2020-04-03 15:49 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+17,500 vol |
17,500 | |
| Filed 2020-04-03 15:47 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$50,750
+35,000 vol $1.45 each |
40,000 | |
| Filed 2017-02-27 17:20 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+26,250 vol |
||
| Filed 2017-02-27 17:19 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$76,125
+52,500 vol $1.45 each |
||
| Filed 2020-04-01 15:56 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+86,000 vol |
283,983 | |
| Filed 2019-08-20 09:04 Tx date 2019-08-19 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$3,016
+1,600 vol $1.89 each |
117,500 | |
| Filed 2019-08-20 09:04 Tx date 2019-08-19 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$15,876
+8,400 vol $1.89 each |
115,900 | |
| Filed 2019-04-15 14:08 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,136
+58,700 vol $1.28 each |
197,983 | |
| Filed 2018-10-23 Tx date 2018-10-09 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$50,000
+50,000 vol $1.00 each |
107,500 | |
| Filed 2018-07-04 Tx date 2018-07-02 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,283 vol |
139,283 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,330
+29,000 vol $1.77 each |
||
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,798
+17,400 vol $1.77 each |
67,400 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,330
+29,000 vol $1.77 each |
79,000 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,532
+11,600 vol $1.77 each |
90,600 | |
| Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,500
+50,000 vol $1.65 each |
50,000 | |
| Filed 2017-03-01 Tx date 2016-07-12 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+26,250 vol |
26,250 | |
| Filed 2017-02-27 Tx date 2016-07-12 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$76,125
+52,500 vol $1.45 each |
57,500 | |
| Filed 2016-07-18 Tx date 2016-07-14 |
$APO
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$7,695
+5,000 vol $1.54 each |
5,000 | |
| Filed 2016-07-13 Tx date 2016-07-12 |
$APO
Acasti Pharma Inc. |
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|